Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphatidyl phospholipase B activity	PNPLA6 PLA2G4B PNPLA7	4.90e-05	11	136	3	GO:0102545
GeneOntologyMolecularFunction	calcium ion binding	CAPN12 PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2 RYR1 RYR2 IQGAP1 SLIT2 FAT2 P4HTM PLA2G4B BAIAP3 PLS1	1.82e-04	749	136	15	GO:0005509
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR1 RYR2	2.74e-04	4	136	2	GO:0005219
GeneOntologyMolecularFunction	phosphatidylinositol-3,4,5-trisphosphate binding	MYO10 HIP1R IQGAP1 FCHSD2	3.44e-04	49	136	4	GO:0005547
GeneOntologyBiologicalProcess	cell junction assembly	DLG5 ASIC1 PCDHB5 PCDHB8 PCDHB4 PCDHB2 LRRTM3 IQGAP1 SLIT2 LRRN3 NRXN2 AGT TLR2 CLDN19 WDR1	5.95e-06	569	137	15	GO:0034329
GeneOntologyBiologicalProcess	cell junction organization	DLG5 RPS6KA5 ASIC1 PCDHB5 PCDHB8 HIP1R PCDHB4 PCDHB2 LRRTM3 IQGAP1 SLIT2 LRRN3 NF1 NRXN2 PLXNC1 AGT TLR2 CLDN19 WDR1 SEMA3E	6.85e-06	974	137	20	GO:0034330
GeneOntologyBiologicalProcess	synapse assembly	DLG5 ASIC1 PCDHB5 PCDHB8 PCDHB4 PCDHB2 LRRTM3 SLIT2 LRRN3 NRXN2 TLR2	6.87e-06	308	137	11	GO:0007416
GeneOntologyBiologicalProcess	synapse organization	DLG5 RPS6KA5 ASIC1 PCDHB5 PCDHB8 HIP1R PCDHB4 PCDHB2 LRRTM3 SLIT2 LRRN3 NF1 NRXN2 PLXNC1 TLR2 SEMA3E	1.30e-05	685	137	16	GO:0050808
GeneOntologyBiologicalProcess	regulation of actin polymerization or depolymerization	HIP1R FHOD3 SLIT2 FCHSD2 TLR2 TENM1 WDR1 PLEKHH2	2.45e-05	177	137	8	GO:0008064
GeneOntologyBiologicalProcess	regulation of actin filament length	HIP1R FHOD3 SLIT2 FCHSD2 TLR2 TENM1 WDR1 PLEKHH2	2.76e-05	180	137	8	GO:0030832
GeneOntologyBiologicalProcess	positive regulation of cell junction assembly	DLG5 LRRTM3 IQGAP1 SLIT2 LRRN3 AGT CLDN19	3.50e-05	136	137	7	GO:1901890
GeneOntologyBiologicalProcess	regulation of cell junction assembly	DLG5 ASIC1 LRRTM3 IQGAP1 SLIT2 LRRN3 NRXN2 AGT TLR2 CLDN19	4.22e-05	309	137	10	GO:1901888
GeneOntologyBiologicalProcess	actin polymerization or depolymerization	HIP1R FHOD3 SLIT2 FCHSD2 TLR2 TENM1 WDR1 PLEKHH2	1.21e-04	222	137	8	GO:0008154
GeneOntologyBiologicalProcess	anatomical structure maturation	TUT4 LGI4 RYR1 FARP2 GH1 NF1 CSPG4 BAIAP3 MTCH1 MOS	1.30e-04	354	137	10	GO:0071695
GeneOntologyBiologicalProcess	positive regulation of translational initiation in response to stress	EIF2AK4 DNAJC3	1.31e-04	3	137	2	GO:0032058
GeneOntologyBiologicalProcess	developmental maturation	TUT4 LGI4 RYR1 FARP2 GH1 ATP6V0D1 NF1 CSPG4 BAIAP3 MTCH1 MOS	1.72e-04	439	137	11	GO:0021700
GeneOntologyCellularComponent	calcium channel complex	RYR1 RYR2 PKD1 TRPV6 TRPV5	1.31e-04	73	140	5	GO:0034704
Domain	LRR	PODNL1 LRRC66 LRRTM3 LRRC70 LGR5 LGI4 SLIT2 LRRN3 TLR2 PKD1 PPP1R37 LRRN2 LUM CD180	3.20e-10	201	139	14	PS51450
Domain	LRR_8	PODNL1 LRRC66 LRRTM3 LRRC70 LGR5 LGI4 SLIT2 LRRN3 TLR2 PKD1 LRRN2 LUM CD180	4.81e-10	171	139	13	PF13855
Domain	LRR_TYP	PODNL1 LRRC66 LRRTM3 LRRC70 LGR5 LGI4 SLIT2 LRRN3 TLR2 PKD1 LRRN2 LUM CD180	7.37e-10	177	139	13	SM00369
Domain	Leu-rich_rpt_typical-subtyp	PODNL1 LRRC66 LRRTM3 LRRC70 LGR5 LGI4 SLIT2 LRRN3 TLR2 PKD1 LRRN2 LUM CD180	7.37e-10	177	139	13	IPR003591
Domain	Leu-rich_rpt	PODNL1 LRRC66 LRRTM3 LRRC70 LGR5 LGI4 SLIT2 LRRN3 TLR2 PKD1 PPP1R37 LRRN2 LUM CD180	1.52e-08	271	139	14	IPR001611
Domain	LRRNT	PODNL1 LRRTM3 LRRC70 LGR5 SLIT2 LRRN3 PKD1 LRRN2 LUM	4.85e-08	98	139	9	IPR000372
Domain	LRRNT	PODNL1 LRRTM3 LRRC70 LGR5 SLIT2 LRRN3 PKD1 LRRN2 LUM	4.85e-08	98	139	9	SM00013
Domain	LRR_1	PODNL1 LRRC66 LRRTM3 LRRC70 LGR5 LGI4 SLIT2 LRRN3 TLR2 LRRN2 LUM CD180	9.01e-08	219	139	12	PF00560
Domain	-	PODNL1 LRRC66 LRRTM3 LRRC70 LGR5 LGI4 SLIT2 LRRN3 TLR2 PKD1 PPP1R37 LRRN2 LUM CD180	1.26e-07	321	139	14	3.80.10.10
Domain	L_dom-like	PODNL1 LRRC66 LRRTM3 LRRC70 LGR5 LGI4 SLIT2 LRRN3 TLR2 PKD1 PPP1R37 LRRN2 LUM CD180	1.64e-07	328	139	14	IPR032675
Domain	Cys-rich_flank_reg_C	LRRC70 LGI4 SLIT2 LRRN3 TLR2 PKD1 LRRN2 CD180	3.57e-07	90	139	8	IPR000483
Domain	LRRCT	LRRC70 LGI4 SLIT2 LRRN3 TLR2 PKD1 LRRN2 CD180	3.57e-07	90	139	8	SM00082
Domain	LRRNT	LRRTM3 LGR5 SLIT2 LRRN3 PKD1 LUM	2.63e-06	53	139	6	PF01462
Domain	LRRCT	LGI4 SLIT2 LRRN3 TLR2 CD180	3.64e-06	32	139	5	PF01463
Domain	Cadherin_C	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2	1.45e-05	42	139	5	IPR032455
Domain	Cadherin_C_2	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2	1.45e-05	42	139	5	PF16492
Domain	TRPV5/TRPV6	TRPV6 TRPV5	5.50e-05	2	139	2	IPR008344
Domain	UPF0028	PNPLA6 PNPLA7	5.50e-05	2	139	2	PS01237
Domain	Cadherin_2	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2	1.23e-04	65	139	5	PF08266
Domain	Cadherin_N	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2	1.23e-04	65	139	5	IPR013164
Domain	Ryanodine_rcpt	RYR1 RYR2	1.64e-04	3	139	2	IPR003032
Domain	Ryanrecept_TM4-6	RYR1 RYR2	1.64e-04	3	139	2	IPR009460
Domain	RyR	RYR1 RYR2	1.64e-04	3	139	2	PF02026
Domain	RR_TM4-6	RYR1 RYR2	1.64e-04	3	139	2	PF06459
Domain	Ryan_recept	RYR1 RYR2	1.64e-04	3	139	2	IPR013333
Domain	Cadherin_CS	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2 FAT2	1.65e-04	109	139	6	IPR020894
Domain	LAM_G_DOMAIN	SLIT2 FAT2 NRXN2 CSPG4	1.78e-04	38	139	4	PS50025
Domain	CADHERIN_1	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2 FAT2	2.01e-04	113	139	6	PS00232
Domain	Cadherin	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2 FAT2	2.01e-04	113	139	6	PF00028
Domain	CADHERIN_2	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2 FAT2	2.10e-04	114	139	6	PS50268
Domain	-	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2 FAT2	2.10e-04	114	139	6	2.60.40.60
Domain	Laminin_G_2	SLIT2 FAT2 NRXN2 CSPG4	2.18e-04	40	139	4	PF02210
Domain	CA	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2 FAT2	2.21e-04	115	139	6	SM00112
Domain	Cadherin-like	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2 FAT2	2.31e-04	116	139	6	IPR015919
Domain	ConA-like_dom	MAMDC4 RYR1 RYR2 SLIT2 FAT2 NRXN2 CSPG4 HERC1	2.38e-04	219	139	8	IPR013320
Domain	Cadherin	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2 FAT2	2.54e-04	118	139	6	IPR002126
Domain	Acyl_Trfase/lysoPLipase	PNPLA6 PLA2G4B PNPLA7	2.54e-04	17	139	3	IPR016035
Domain	LamG	SLIT2 FAT2 NRXN2 CSPG4	3.17e-04	44	139	4	SM00282
Domain	LDLRA_1	TMPRSS9 MAMDC4 PKD1 C6	4.43e-04	48	139	4	PS01209
Domain	LDLRA_2	TMPRSS9 MAMDC4 PKD1 C6	4.80e-04	49	139	4	PS50068
Domain	Somatotropin_CS	GH1 GH2	5.42e-04	5	139	2	IPR018116
Domain	RIH_assoc-dom	RYR1 RYR2	8.09e-04	6	139	2	IPR013662
Domain	SOMATOTROPIN_2	GH1 GH2	8.09e-04	6	139	2	PS00338
Domain	HNOB_dom_associated	GUCY1B2 GUCY2D	8.09e-04	6	139	2	IPR011645
Domain	SOMATOTROPIN_1	GH1 GH2	8.09e-04	6	139	2	PS00266
Domain	Ins145_P3_rec	RYR1 RYR2	8.09e-04	6	139	2	PF08709
Domain	RIH_assoc	RYR1 RYR2	8.09e-04	6	139	2	PF08454
Domain	RIH_dom	RYR1 RYR2	8.09e-04	6	139	2	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR2	8.09e-04	6	139	2	IPR014821
Domain	Ryanodine_recept-rel	RYR1 RYR2	8.09e-04	6	139	2	IPR015925
Domain	Hormone_1	GH1 GH2	8.09e-04	6	139	2	PF00103
Domain	-	RYR1 RYR2	8.09e-04	6	139	2	1.25.10.30
Domain	HNOBA	GUCY1B2 GUCY2D	8.09e-04	6	139	2	PF07701
Domain	RYDR_ITPR	RYR1 RYR2	8.09e-04	6	139	2	PF01365
Domain	Laminin_G	SLIT2 FAT2 NRXN2 CSPG4	9.13e-04	58	139	4	IPR001791
Domain	Clathrin	CLTCL1 TGFBRAP1	1.13e-03	7	139	2	PF00637
Domain	Somatotropin	GH1 GH2	1.13e-03	7	139	2	IPR001400
Domain	CHCR	CLTCL1 TGFBRAP1	1.13e-03	7	139	2	PS50236
Domain	Clathrin_H-chain/VPS_repeat	CLTCL1 TGFBRAP1	1.50e-03	8	139	2	IPR000547
Domain	MYTH4	MYO10 PLEKHH2	1.91e-03	9	139	2	PS51016
Domain	Patatin	PNPLA6 PNPLA7	1.91e-03	9	139	2	PF01734
Domain	PNPLA	PNPLA6 PNPLA7	1.91e-03	9	139	2	PS51635
Domain	MyTH4	MYO10 PLEKHH2	1.91e-03	9	139	2	SM00139
Domain	Patatin/PLipase_A2-rel	PNPLA6 PNPLA7	1.91e-03	9	139	2	IPR002641
Domain	MyTH4_dom	MYO10 PLEKHH2	1.91e-03	9	139	2	IPR000857
Domain	MyTH4	MYO10 PLEKHH2	1.91e-03	9	139	2	PF00784
Domain	MIR	RYR1 RYR2	2.38e-03	10	139	2	PF02815
Domain	MIR_motif	RYR1 RYR2	2.38e-03	10	139	2	IPR016093
Domain	Glyco_transf_8	GLT8D2 GYG1	2.38e-03	10	139	2	PF01501
Domain	MIR	RYR1 RYR2	2.38e-03	10	139	2	PS50919
Domain	MIR	RYR1 RYR2	2.38e-03	10	139	2	SM00472
Domain	Glyco_trans_8	GLT8D2 GYG1	2.38e-03	10	139	2	IPR002495
Domain	Kinase-like_dom	RPS6KA5 AXL ACAD11 MAP4K5 PI4KB GUCY2D DCLK2 EIF2AK4 PRKDC ALPK2 MOS	2.45e-03	542	139	11	IPR011009
Domain	TRP_channel	TRPV6 TRPV5	2.89e-03	11	139	2	IPR004729
Domain	DHR-1_domain	DOCK3 DOCK6	2.89e-03	11	139	2	IPR027007
Domain	DHR_2	DOCK3 DOCK6	2.89e-03	11	139	2	PS51651
Domain	DHR_1	DOCK3 DOCK6	2.89e-03	11	139	2	PS51650
Domain	DHR-2	DOCK3 DOCK6	2.89e-03	11	139	2	PF06920
Domain	DOCK	DOCK3 DOCK6	2.89e-03	11	139	2	IPR026791
Domain	DOCK_C	DOCK3 DOCK6	2.89e-03	11	139	2	IPR010703
Domain	Laminin_G_1	SLIT2 CSPG4	2.89e-03	11	139	2	PF00054
Domain	DOCK-C2	DOCK3 DOCK6	2.89e-03	11	139	2	PF14429
Domain	DHR-2	DOCK3 DOCK6	2.89e-03	11	139	2	IPR027357
Domain	Ldl_recept_a	TMPRSS9 MAMDC4 C6	4.56e-03	45	139	3	PF00057
Domain	RasGAP	IQGAP1 NF1	4.72e-03	14	139	2	SM00323
Domain	RasGAP_CS	IQGAP1 NF1	4.72e-03	14	139	2	IPR023152
Domain	FERM_M	MYO10 FARP2 PLEKHH2	4.85e-03	46	139	3	PF00373
Domain	RasGAP	IQGAP1 NF1	5.42e-03	15	139	2	PF00616
Domain	RAS_GTPASE_ACTIV_1	IQGAP1 NF1	5.42e-03	15	139	2	PS00509
Domain	PI3/4_kinase_CS	PI4KB PRKDC	5.42e-03	15	139	2	IPR018936
Domain	CNH	MAP4K5 TGFBRAP1	5.42e-03	15	139	2	PF00780
Domain	RAS_GTPASE_ACTIV_2	IQGAP1 NF1	5.42e-03	15	139	2	PS50018
Domain	CNH	MAP4K5 TGFBRAP1	5.42e-03	15	139	2	PS50219
Domain	CNH_dom	MAP4K5 TGFBRAP1	5.42e-03	15	139	2	IPR001180
Domain	Ank_2	ANKRD29 TRPV6 RAI14 TNKS TRPV5 PPP1R12C	5.49e-03	215	139	6	PF12796
Domain	-	SLIT2 FAT2 NRXN2 CSPG4	5.54e-03	95	139	4	2.60.120.200
Domain	-	MYO10 FARP2 PLEKHH2	5.79e-03	49	139	3	1.20.80.10
Domain	LDrepeatLR_classA_rpt	TMPRSS9 MAMDC4 C6	5.79e-03	49	139	3	IPR002172
Domain	LDLa	TMPRSS9 MAMDC4 C6	5.79e-03	49	139	3	SM00192
Domain	FERM_central	MYO10 FARP2 PLEKHH2	5.79e-03	49	139	3	IPR019748
Pubmed	The human and murine protocadherin-beta one-exon gene families show high evolutionary conservation, despite the difference in gene number.	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2	1.51e-08	20	141	5	11322959
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DOCK3 B4GAT1 USP11 NDUFA10 STAT3 IQGAP1 WDR3 UBA7 P4HTM PKD1 MTMR3 AKR1C3 ENPP5 LRRN2 RAI14 TNKS DCLK2 PRKDC SNRNP200 SLX4 DNMT1	5.76e-08	1285	141	21	35914814
Pubmed	Protocadherins.	PCDHB5 PCDHB8 PCDHB4 PCDHB2	1.80e-07	13	141	4	12231349
Pubmed	K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors.	AMER1 USP11 AXL FARP2 ZCCHC14 RIF1 PNPLA6 ACAD11 NFIC HERC1 MTCH1 DNAJC3 DNMT1 MOCOS	1.87e-07	604	141	14	38803224
Pubmed	Activating Hair Follicle Stem Cells via R-spondin2 to Stimulate Hair Growth.	LGR5 AXIN2 PRKDC	2.60e-07	4	141	3	27109869
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2 FAT2	5.00e-07	72	141	6	10380929
Pubmed	Postsynaptic and differential localization to neuronal subtypes of protocadherin beta16 in the mammalian central nervous system.	PCDHB5 PCDHB15 PCDHB8 PCDHB4	5.91e-07	17	141	4	18279309
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	CLTCL1 USP11 PHKB RIF1 SF3B3 GYG1 PPP1R37 RAI14 PRKDC HERC1 DNAJC3 SNRNP200 PPP1R12C	6.66e-07	573	141	13	28330616
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2 FAT2	7.47e-07	77	141	6	10835267
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2 FAT2	9.37e-07	80	141	6	10716726
Pubmed	Distinct and Cooperative Functions for the Protocadherin-α, -β and -γ Clusters in Neuronal Survival and Axon Targeting.	PCDHB15 PCDHB8 PCDHB4 PCDHB2	9.57e-07	19	141	4	28066179
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	TUT4 CLTCL1 NAA60 SLIT2 LINS1 RIF1 FAM193A NFIC PI4KB PKD1 DCLK2 WDR1 ZNF281 DHX29 BAIAP3 DNMT1	1.20e-06	925	141	16	28986522
Pubmed	Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes.	GH1 GH2 FGF21	1.29e-06	6	141	3	21849508
Pubmed	Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice.	GH1 GH2 FGF21	1.29e-06	6	141	3	25811804
Pubmed	Inhibition of growth hormone signaling by the fasting-induced hormone FGF21.	GH1 GH2 FGF21	2.26e-06	7	141	3	18585098
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2	3.60e-06	57	141	5	32633719
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2	3.93e-06	58	141	5	30377227
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	RPS6KA5 IQGAP1 SLIT2 PHKB NF1 FAM193A DZIP3 TNKS DHX29 DNAJC3 DNMT1	4.11e-06	475	141	11	31040226
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	TUT4 CLTCL1 USP11 FCHSD2 SF3B3 PRKDC RPS10P5 SNRNP200	5.64e-06	235	141	8	30258100
Pubmed	Casein kinase 1α is required to maintain murine hypothalamic pro-opiomelanocortin expression.	PCSK1 STAT3 GH1 GH2	7.48e-06	31	141	4	37168577
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2	8.66e-06	68	141	5	11230163
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DLG5 MARCHF6 ZNF507 HIP1R IQGAP1 SF3B3 NRXN2 RAI14 EIF2AK4 DOCK6 SEMA3E	1.13e-05	529	141	11	14621295
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DOCK3 KIAA0930 MAN2A2 CLTCL1 MYO10 HIP1R RYR1 ZCCHC14 PNPLA6 PLA2G4B CSPG4 PKD1 MTMR3 PRKDC HERC1 DOCK6	1.13e-05	1105	141	16	35748872
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ZNF536 FXR2 AXL LRRC70 RYR1 RYR2 RAD51AP2 NF1 GUCY1B2 ACAD11 PI4KB ZNF281	1.22e-05	638	141	12	31182584
Pubmed	Network organization of the human autophagy system.	FXR2 USP11 TFCP2 IQGAP1 RIF1 TGFBRAP1 GYG1 PI4KB DZIP3 PRKDC	1.27e-05	437	141	10	20562859
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2	1.31e-05	74	141	5	10817752
Pubmed	Alteration of calcium homeostasis in primary preeclamptic syncytiotrophoblasts: effect on calcium exchange in placenta.	TRPV6 TRPV5	1.63e-05	2	141	2	20178461
Pubmed	The TRPV5/6 calcium channels contain multiple calmodulin binding sites with differential binding properties.	TRPV6 TRPV5	1.63e-05	2	141	2	22354706
Pubmed	Diverse calcium channel types are present in the human placental syncytiotrophoblast basal membrane.	TRPV6 TRPV5	1.63e-05	2	141	2	16564089
Pubmed	Endogenous expression of TRPV5 and TRPV6 calcium channels in human leukemia K562 cells.	TRPV6 TRPV5	1.63e-05	2	141	2	19295174
Pubmed	Human TRPV5 and TRPV6: key players in cadmium and zinc toxicity.	TRPV6 TRPV5	1.63e-05	2	141	2	23968883
Pubmed	TRPV5 and TRPV6 are expressed in placenta and bone tissues during pregnancy in mice.	TRPV6 TRPV5	1.63e-05	2	141	2	30916584
Pubmed	Ryanodine receptor oligomeric interaction: identification of a putative binding region.	RYR1 RYR2	1.63e-05	2	141	2	14722100
Pubmed	Structural and functional interactions within ryanodine receptor.	RYR1 RYR2	1.63e-05	2	141	2	26009179
Pubmed	Metabolic Responses to Dietary Protein Restriction Require an Increase in FGF21 that Is Delayed by the Absence of GCN2.	FGF21 EIF2AK4	1.63e-05	2	141	2	27396336
Pubmed	A single amino acid mutation results in a rapid inactivation of epithelial calcium channels.	TRPV6 TRPV5	1.63e-05	2	141	2	11846401
Pubmed	Distinct contributions of the innate immune receptors TLR2 and RP105 to formation and architecture of structured lung granulomas in mice infected with Mycobacterium tuberculosis.	TLR2 CD180	1.63e-05	2	141	2	36370035
Pubmed	Expression and prognostic roles of TRPV5 and TRPV6 in non-small cell lung cancer after curative resection.	TRPV6 TRPV5	1.63e-05	2	141	2	24761864
Pubmed	STAT3-induced WDR1 overexpression promotes breast cancer cell migration.	STAT3 WDR1	1.63e-05	2	141	2	27521604
Pubmed	Fast and slow inactivation kinetics of the Ca2+ channels ECaC1 and ECaC2 (TRPV5 and TRPV6). Role of the intracellular loop located between transmembrane segments 2 and 3.	TRPV6 TRPV5	1.63e-05	2	141	2	12077127
Pubmed	Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 promotes cell proliferation and migration by upregulating DNMT1 via STAT3 activation.	STAT3 DNMT1	1.63e-05	2	141	2	24675762
Pubmed	Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion.	RYR1 RYR2	1.63e-05	2	141	2	15033925
Pubmed	[The functional characteristics oF TRPV5 and TRPV6 channels in normal and transformed human blood lymphocytes].	TRPV6 TRPV5	1.63e-05	2	141	2	24592736
Pubmed	STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes.	STAT3 DNMT1	1.63e-05	2	141	2	16861352
Pubmed	Intracellular ATP supports TRPV6 activity via lipid kinases and the generation of PtdIns(4,5) P₂.	PI4KB TRPV6	1.63e-05	2	141	2	21810903
Pubmed	Identification of an insulin-regulated lysophospholipase with homology to neuropathy target esterase.	PNPLA6 PNPLA7	1.63e-05	2	141	2	18086666
Pubmed	Structural conservation of the genes encoding CaT1, CaT2, and related cation channels.	TRPV6 TRPV5	1.63e-05	2	141	2	11549322
Pubmed	[TRPV5 and TRPV6 calcium channels in human T cells].	TRPV6 TRPV5	1.63e-05	2	141	2	19140341
Pubmed	Transcription factor ZFHX3 regulates calcium influx in mammary epithelial cells in part via the TRPV6 calcium channel.	TRPV6 ZFHX3	1.63e-05	2	141	2	31519324
Pubmed	Aldosterone-induced ENaC and basal Na+/K+-ATPase trafficking via protein kinase D1-phosphatidylinositol 4-kinaseIIIβ trans Golgi signalling in M1 cortical collecting duct cells.	PI4KB PKD1	1.63e-05	2	141	2	23541637
Pubmed	RORα modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis.	RORA SEMA3E	1.63e-05	2	141	2	28646017
Pubmed	First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation.	TRPV6 TRPV5	1.63e-05	2	141	2	25164318
Pubmed	Role of GCN2-Independent Signaling Through a Noncanonical PERK/NRF2 Pathway in the Physiological Responses to Dietary Methionine Restriction.	FGF21 EIF2AK4	1.63e-05	2	141	2	26936965
Pubmed	Proliferation in the developing intestine is regulated by the endosomal protein Endotubin.	LGR5 MAMDC4	1.63e-05	2	141	2	34411593
Pubmed	Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain.	RYR1 RYR2	1.63e-05	2	141	2	25370123
Pubmed	Bacillus subtilis programs the differentiation of intestinal secretory lineages to inhibit Salmonella infection.	LGR5 TLR2	1.63e-05	2	141	2	36170821
Pubmed	Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity.	PNPLA6 PNPLA7	1.63e-05	2	141	2	12640454
Pubmed	Expression of calcium channels along the differentiation of cultured trophoblast cells from human term placenta.	TRPV6 TRPV5	1.63e-05	2	141	2	12390878
Pubmed	Skeletal and cardiac ryanodine receptors exhibit different responses to Ca2+ overload and luminal ca2+.	RYR1 RYR2	1.63e-05	2	141	2	17259277
Pubmed	Interaction of the epithelial Ca2+ channels TRPV5 and TRPV6 with the intestine- and kidney-enriched PDZ protein NHERF4.	TRPV6 TRPV5	1.63e-05	2	141	2	16565876
Pubmed	Age-dependent alterations in Ca2+ homeostasis: role of TRPV5 and TRPV6.	TRPV6 TRPV5	1.63e-05	2	141	2	16705151
Pubmed	Structure and Function of the Human Ryanodine Receptors and Their Association with Myopathies-Present State, Challenges, and Perspectives.	RYR1 RYR2	1.63e-05	2	141	2	32899693
Pubmed	Non-equivalence of Wnt and R-spondin ligands during Lgr5+ intestinal stem-cell self-renewal.	LGR5 AXIN2	1.63e-05	2	141	2	28467820
Pubmed	Regulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor alpha.	FGF21 RORA	1.63e-05	2	141	2	20332535
Pubmed	DNA methylation is required for the control of stem cell differentiation in the small intestine.	LGR5 DNMT1	1.63e-05	2	141	2	24637118
Pubmed	Expression of transient receptor potential vanilloid channels TRPV5 and TRPV6 in retinal pigment epithelium.	TRPV6 TRPV5	1.63e-05	2	141	2	20405023
Pubmed	Regulatory roles of tankyrase 1 at telomeres and in DNA repair: suppression of T-SCE and stabilization of DNA-PKcs.	TNKS PRKDC	1.63e-05	2	141	2	21037379
Pubmed	Transcription factor LSF-DNMT1 complex dissociation by FQI1 leads to aberrant DNA methylation and gene expression.	TFCP2 DNMT1	1.63e-05	2	141	2	27845898
Pubmed	The human growth hormone gene family: structure and evolution of the chromosomal locus.	GH1 GH2	1.63e-05	2	141	2	6306568
Pubmed	Homo- and heterotetrameric architecture of the epithelial Ca2+ channels TRPV5 and TRPV6.	TRPV6 TRPV5	1.63e-05	2	141	2	12574114
Pubmed	Recent advances in understanding the ryanodine receptor calcium release channels and their role in calcium signalling.	RYR1 RYR2	1.63e-05	2	141	2	30542613
Pubmed	Ryanodine receptors are expressed and functionally active in mouse spermatogenic cells and their inhibition interferes with spermatogonial differentiation.	RYR1 RYR2	1.63e-05	2	141	2	15280431
Pubmed	Expression of the ryanodine receptor isoforms in immune cells.	RYR1 RYR2	1.63e-05	2	141	2	11673493
Pubmed	B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators.	RYR1 RYR2	1.63e-05	2	141	2	11673462
Pubmed	Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival.	RORA DNMT1	1.63e-05	2	141	2	29313974
Pubmed	Regulation of the mouse epithelial Ca2(+) channel TRPV6 by the Ca(2+)-sensor calmodulin.	TRPV6 TRPV5	1.63e-05	2	141	2	15123711
Pubmed	STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma.	STAT3 NF1	1.63e-05	2	141	2	30542122
Pubmed	Single-channel activities of the human epithelial Ca2+ transport proteins CaT1 and CaT2.	TRPV6 TRPV5	1.63e-05	2	141	2	11719848
Pubmed	Concerted action of associated proteins in the regulation of TRPV5 and TRPV6.	TRPV6 TRPV5	1.63e-05	2	141	2	17233615
Pubmed	Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels.	RYR1 RYR2	1.63e-05	2	141	2	18618700
Pubmed	The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivo.	STAT3 NF1	1.63e-05	2	141	2	20124472
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	RYR1 RYR2 TRPV6 TRPV5	1.72e-05	38	141	4	30786075
Pubmed	Atbf1 is required for the Pit1 gene early activation.	GH1 GH2 ZFHX3	1.81e-05	13	141	3	18272476
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	IQGAP1 PHKB EIF2AK4 PRKDC DOCK6 SNRNP200 DNMT1	1.97e-05	202	141	7	33005030
Pubmed	Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma.	AXIN2 GH1 GH2 PRKDC	2.11e-05	40	141	4	29180744
Pubmed	Polymorphisms in innate immunity genes and risk of childhood leukemia.	DLG5 GPR108 STAT3 ACAD11 TLR2 C6 CD180	2.23e-05	206	141	7	20438785
Pubmed	Risk of meningioma and common variation in genes related to innate immunity.	DLG5 GPR108 STAT3 ACAD11 TLR2 C6 CD180	2.30e-05	207	141	7	20406964
Pubmed	Common variation in genes related to innate immunity and risk of adult glioma.	DLG5 GPR108 STAT3 ACAD11 TLR2 C6 CD180	2.37e-05	208	141	7	19423540
Pubmed	Developmental waves of mechanosensitivity acquisition in sensory neuron subtypes during embryonic development.	ASIC1 PKD1 TRPV6 TRPV5	3.10e-05	44	141	4	19322198
Pubmed	Physical and linkage mapping of human chromosome 17 loci to dog chromosomes 9 and 5.	GH1 GH2 NF1	3.51e-05	16	141	3	9177778
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	USP11 HIP1R IQGAP1 WDR3 RIF1 SF3B3 NF1 PNPLA6 MAP4K5 PPP1R37 RAI14 PRKDC WDR1 ZNF281 DHX29 SNRNP200 DNMT1	3.63e-05	1353	141	17	29467282
Pubmed	Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways.	IQGAP1 UBA7 WDR1 ZNF281 SNRNP200 PLS1	3.81e-05	152	141	6	16009940
Pubmed	Nescient helix-loop-helix 2 interacts with signal transducer and activator of transcription 3 to regulate transcription of prohormone convertase 1/3.	PCSK1 STAT3	4.88e-05	3	141	2	18356286
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR1 RYR2	4.88e-05	3	141	2	18403125
Pubmed	OTUD6A in tubular epithelial cells mediates angiotensin II-induced kidney injury by targeting STAT3.	STAT3 AGT	4.88e-05	3	141	2	38105755
Pubmed	Interleukin-6 deficiency attenuates angiotensin II-induced cardiac pathogenesis with increased myocyte hypertrophy.	STAT3 AGT	4.88e-05	3	141	2	29079193
Pubmed	Global loss of imprinting leads to widespread tumorigenesis in adult mice.	PRKDC DNMT1	4.88e-05	3	141	2	16226703
Pubmed	Evaluation of AXIN1 and AXIN2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines.	AXIN2 TNKS	4.88e-05	3	141	2	33811251
Pubmed	Lack of pendrin HCO3- transport elevates vestibular endolymphatic [Ca2+] by inhibition of acid-sensitive TRPV5 and TRPV6 channels.	TRPV6 TRPV5	4.88e-05	3	141	2	17200157
Pubmed	Dopamine D1 receptor signaling system regulates ryanodine receptor expression in ethanol physical dependence.	RYR1 RYR2	4.88e-05	3	141	2	23278119
Cytoband	5q31	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2	2.98e-05	115	141	5	5q31
Cytoband	8q11	PRKDC MOS	1.39e-04	6	141	2	8q11
Cytoband	18q12	FHOD3 MOCOS	7.15e-04	13	141	2	18q12
Cytoband	16p13.3	NAA60 PKD1 BAIAP3 DNASE1 SLX4	9.78e-04	244	141	5	16p13.3
GeneFamily	Clustered protocadherins	PCDHB5 PCDHB15 PCDHB8 PCDHB4 PCDHB2	1.84e-05	64	92	5	20
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR2	7.66e-05	3	92	2	287
GeneFamily	Growth hormone family	GH1 GH2	3.79e-04	6	92	2	1175
GeneFamily	Glycosyltransferase family 8	GLT8D2 GYG1	9.01e-04	9	92	2	436
GeneFamily	Patatin like phospholipase domain containing	PNPLA6 PNPLA7	1.12e-03	10	92	2	466
GeneFamily	Ankyrin repeat domain containing	ANKRD29 TRPV6 RAI14 TNKS TRPV5 PPP1R12C	1.48e-03	242	92	6	403
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	MYO10 FARP2 PLEKHH2	2.10e-03	50	92	3	1293
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	DOCK3 TUT4 PCDHB4 FHOD3 LGR5 RYR2 LRRN3 FAT2 ATP8A1 NRXN2 PRSS53 PLXNC1 RASGEF1B TENM1 RORA ZFHX3 TNKS DCLK2 HERC1 SEMA3E	2.04e-06	1106	141	20	M39071
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	TUT4 MYO10 RIF1 FCHSD2 NF1 ATP8A1 TNKS HERC1	6.16e-06	180	141	8	M8239
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	KIAA0930 ASIC1 AXL PCDHB8 HIP1R PCDHB4 FHOD3 LRRN3 FAM193A ATP8A1 PLXNC1 NFIC MAP4K5 RASGEF1B ENPP5 RORA ZFHX3 WDR1 PLS1	9.84e-06	1124	141	19	MM1070
Coexpression	GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_UP	RPS6KA5 AXIN2 IQGAP1 FCHSD2 ANGEL2 MTMR3 TNKS	2.64e-05	160	141	7	M7116
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	KIAA0930 ASIC1 AXL HIP1R PCDHB4 FHOD3 LRRN3 FAM193A ATP8A1 PLXNC1 NFIC MAP4K5 RASGEF1B ENPP5 RORA ZFHX3 WDR1 PLS1	2.71e-05	1102	141	18	M2369
Coexpression	FIRESTEIN_PROLIFERATION	AXL PHKB NF1 TRPV6 PRKDC TRPV5 PPP1R12C	3.34e-05	166	141	7	M5354
Coexpression	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP	GH1 GH2 PLA2G4B PI4KB AKR1C3	5.02e-05	74	141	5	MM769
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AXL CBFA2T3 RYR2 SLIT2 PLXNC1 CSPG4 PLEKHH2	1.20e-06	170	141	7	5570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)\|343B / Donor, Lineage, Cell class and subclass (all cells)	PCDHB15 PCDHB4 LGR5 RYR2 KLHL22 NRXN2 LUM	1.57e-06	177	141	7	e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	PCDHB15 PCDHB4 LGR5 RYR2 KLHL22 NRXN2 LUM	1.57e-06	177	141	7	43ba6f12c2fb32698a420bf799d46ac1b558f146
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO10 CBFA2T3 LGI4 RYR2 CSPG4 ZFHX3 DOCK6	2.26e-06	187	141	7	86250acf088ec0c4800a0dfa031b0d4f7e52c342
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RYR2 SLIT2 CSPG4 ZFHX3 RAI14 LUM MOCOS	2.43e-06	189	141	7	d0c7549be4f77520c23dddf4f94d0fcad0081e37
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	RYR2 SLIT2 GYG1 RORA ZFHX3 LUM SEMA3E	2.51e-06	190	141	7	7986586b7c82e91c71102cc8c4d7a689ae63ab4d
ToppCell	droplet-Limb_Muscle-nan-18m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK3 ZNF536 LGI4 LRRN3 CLDN19 ALPK2 SEMA3E	2.51e-06	190	141	7	e2481bd5166fde2cdc0c3824894f2bccb8294fdd
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ASIC1 HIP1R LRRTM3 NRXN2 CSPG4 AKR1C3 SEMA3E	2.51e-06	190	141	7	6c7e1086c0a274cd5527c3104106e372811c9905
ToppCell	RV-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	DOCK3 FHOD3 LRRTM3 VWA7 RYR2 ALPK2	2.55e-06	122	141	6	1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3
ToppCell	ASK454-Mesenchymal\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	PCDHB2 LGI4 RYR2 SLIT2 CSPG4 TENM1 LUM	2.60e-06	191	141	7	e30ae7a12439f8a79820b13f03e822c1223fd0cb
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AXL FHOD3 LGR5 AXIN2 AGT CSPG4 LUM	2.60e-06	191	141	7	fd8331c7abdd999f55ba43d307945c6abfccbf84
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	RYR2 SLIT2 GYG1 RORA LUM PLEKHH2 SEMA3E	2.60e-06	191	141	7	fa380a8752de158974b2ae5e741573439719cc0d
ToppCell	ASK454-Mesenchymal-Fibroblast\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	PCDHB2 LGI4 RYR2 SLIT2 CSPG4 TENM1 LUM	2.60e-06	191	141	7	1726add3f392a061536b7aff72ba84303f4a0b1f
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO10 RYR2 SLIT2 GYG1 RORA LUM PLEKHH2	2.89e-06	194	141	7	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	droplet-Lung-3m-Mesenchymal-myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZNF536 AXL FHOD3 LGR5 AGT CSPG4 LUM	2.89e-06	194	141	7	c992e3357f4bf3069f8d697803e5785e49a2ef0a
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	GLT8D2 SLIT2 GYG1 RORA LUM PLEKHH2 SEMA3E	2.89e-06	194	141	7	71d3c7448b1734de54187f902f65649f9283bd4c
ToppCell	P28-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	GLT8D2 ZNF536 FHOD3 LGR5 AGT RORA LUM	2.89e-06	194	141	7	3c661c6768c3f05d2aba03d329adb257ca201b2d
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ASIC1 HIP1R LRRTM3 NRXN2 CSPG4 AKR1C3 SEMA3E	3.09e-06	196	141	7	f374cb3ec31c6eef2cef9e07547bfd1e380553af
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ASIC1 HIP1R LRRTM3 NRXN2 CSPG4 AKR1C3 SEMA3E	3.09e-06	196	141	7	671c380b58d7f634b4fbec38c357d357ea4f3535
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GLT8D2 ZNF536 LGR5 SLIT2 TENM1 LUM PLEKHH2	3.53e-06	200	141	7	fb53be20392a8309a7393774c774a1b1aec6e676
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_A\|E18.5-samps / Age Group, Lineage, Cell class and subclass	TMPRSS9 FAM114A1 ZNF536 FHOD3 GUCY1B2 AGT	7.78e-06	148	141	6	5729826e8d45bf995e2efa6707c49e264d12d112
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8\|TCGA-Thymus / Sample_Type by Project: Shred V9	PODNL1 GLT8D2 LGR5 SLIT2 PLEKHH2 SEMA3E	8.73e-06	151	141	6	5906562efd36fbcb91f96e0a0d3a8fe999ba1e79
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZNF536 SLIT2 AGT RORA PNPLA7 PLEKHH2	1.09e-05	157	141	6	f147e24f2ece82e1c54750868954d09b3c461804
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Epithelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC66 VWA7 FCHSD2 PRSS53 FGF21 LRRN2	1.13e-05	158	141	6	12661763d1c309106801cb710c04cd2b62d16cba
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC66 VWA7 FCHSD2 PRSS53 FGF21 LRRN2	1.13e-05	158	141	6	e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC66 VWA7 FCHSD2 PRSS53 FGF21 LRRN2	1.13e-05	158	141	6	0792c39e6fc0745095af7812de2d50949540d60f
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Brinp3\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RASGEF1B TRPV6 ZFHX3 RAI14 CLCF1 SEMA3E	1.35e-05	163	141	6	b0aa4a620bd58011225b42ea6dda04e3101ba342
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AXL PCDHB4 LGI4 RYR2 AGT CSPG4	1.55e-05	167	141	6	e228b8373ffd4436e6b944e26d0fadf3ac289b21
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AXL PCDHB4 LGI4 RYR2 AGT CSPG4	1.55e-05	167	141	6	7cb1b11e8e24a10115e46ffbb74889e672a7a026
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AXL PCDHB4 LGI4 RYR2 AGT CSPG4	1.55e-05	167	141	6	bb53a478b5d821d6d82c15bc4ed075b67682457c
ToppCell	facs-Heart-LV-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLG5 NRXN2 AGT PPP1R37 RORA PLEKHH2	1.66e-05	169	141	6	849a8f8509c58d65462a09c84d58b6ecdc8934f5
ToppCell	356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	PCDHB4 RYR2 SLIT2 NRXN2 LUM PLEKHH2	2.15e-05	177	141	6	cdfd2f0ee2f692271b1525e414b0f645cdadb1f6
ToppCell	356C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|356C / Donor, Lineage, Cell class and subclass (all cells)	PCDHB4 RYR2 SLIT2 NRXN2 LUM PLEKHH2	2.15e-05	177	141	6	db222faaecbe5600da39277243c4e7e764eb63c9
ToppCell	PND01-03-samps-Mesenchymal-Myofibroblast\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	GLT8D2 FAM114A1 FGF21 AGT RORA LUM	2.52e-05	182	141	6	812dac35b9aa05be48258082e007f6c00e7b4dd8
ToppCell	droplet-Limb_Muscle-nan-21m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF536 LGI4 SLIT2 CSPG4 CLDN19 SEMA3E	2.52e-05	182	141	6	a512863304fad80acaab60a8c6107eb7c9cbac99
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF536 PCDHB5 PCDHB15 LGI4 CSPG4 SEMA3E	2.59e-05	183	141	6	876b4f128c2168fdae7488201ff44f19c06c8415
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF536 PCDHB5 PCDHB15 LGI4 CSPG4 SEMA3E	2.59e-05	183	141	6	b190b650e61b1b20baf5e42d04acac82d3fd1400
ToppCell	PND07-28-samps-Epithelial-Alveolar_epithelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	MACC1 FAT2 ATP8A1 TRPV6 RAI14 C6	2.59e-05	183	141	6	23e55f88a802a9299d2773f9394970e86e8bbfaa
ToppCell	PND07-28-samps-Epithelial-Alveolar_epithelial-AT2\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	MACC1 FAT2 ATP8A1 TRPV6 RAI14 C6	2.59e-05	183	141	6	0a69e22750dd8b66ab988cf36d0dd2b59e2f7d26
ToppCell	Adult-Mesenchymal-pericyte_cell-D122\|Adult / Lineage, Cell type, age group and donor	MYO10 AXL LGI4 RYR2 CSPG4 DOCK6	2.59e-05	183	141	6	fc31a43a637423cb3bb9aa184a3a889a0b9aaea6
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF536 PCDHB5 PCDHB15 LGI4 CSPG4 SEMA3E	2.59e-05	183	141	6	8330c39184ce076e1f95fd3725b68af551d89db0
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	GLT8D2 RORA ZFHX3 RAI14 PLEKHH2 SEMA3E	2.76e-05	185	141	6	1ac6a32cc56d5d819649bdd99518e2ead0eead4c
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ZNF536 RYR2 RORA ZFHX3 LUM SEMA3E	2.84e-05	186	141	6	7def03dd856b765bd3f493288641981c4f7fd26e
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO10 CBFA2T3 LGI4 RYR2 CSPG4 DOCK6	2.84e-05	186	141	6	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	droplet-Limb_Muscle-nan-18m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK3 ZNF536 PCDHB8 LGI4 LRRN3 CLDN19	3.02e-05	188	141	6	8385fd384fc55e3b17802bb6698eb93b2c16d7f2
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 ZNF536 ZNF268 RYR2 FARP2 LUM	3.02e-05	188	141	6	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 ZNF536 ZNF268 RYR2 FARP2 LUM	3.02e-05	188	141	6	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 ZNF536 ZNF268 RYR2 FARP2 LUM	3.02e-05	188	141	6	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO10 CBFA2T3 LGI4 RYR2 CSPG4 DOCK6	3.02e-05	188	141	6	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	droplet-Limb_Muscle-nan-18m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK3 ZNF536 PCDHB8 LGI4 LRRN3 CLDN19	3.02e-05	188	141	6	cb9d0b48e2fd9cc576132803273b9c0382900944
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AXL RYR2 SLIT2 AGT CSPG4 ZFHX3	3.11e-05	189	141	6	975e7aa3b862a8b07c2ab8426a14f5cc54998aca
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 ZNF536 AXL RYR2 SLIT2 ZFHX3	3.11e-05	189	141	6	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	MYO10 LGI4 RYR2 CSPG4 DCLK2 DOCK6	3.11e-05	189	141	6	d7ed96add29f219183c802895fbff519b627f635
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DOCK3 ANKRD29 MACC1 HIP1R ATP8A1 PLS1	3.20e-05	190	141	6	625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AXL RYR2 SLIT2 AGT CSPG4 ZFHX3	3.20e-05	190	141	6	73d94fbae92029745989a8712eed8b99fd84c193
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO10 STAT3 RYR2 SLIT2 RORA PLEKHH2	3.30e-05	191	141	6	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 ZNF536 FHOD3 RYR2 LUM PLEKHH2	3.30e-05	191	141	6	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO10 CBFA2T3 LGI4 RYR2 CSPG4 DOCK6	3.30e-05	191	141	6	1626b23a57429f835fddc052e3c57f63a4e5b8bb
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 ZNF536 AXL RYR2 SLIT2 ZFHX3	3.30e-05	191	141	6	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TUT4 USP11 ZNF507 LRRN3 ATP8A1 RORA	3.30e-05	191	141	6	696921a4f160b6b55698652488ed781e855e5e51
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO10 CBFA2T3 LGI4 RYR2 CSPG4 DOCK6	3.30e-05	191	141	6	716dfa7fccbd62b5f574792e68a26dc6c45511dc
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	MYO10 RYR2 SLIT2 LRRN3 LUM PLEKHH2	3.39e-05	192	141	6	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Cdkn1c_(Cdkn1c)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	RAB19 PODNL1 GUCY2D MOS	3.44e-05	58	141	4	17a83e082c819692eaf4f49981f1127dd98e0a0c
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Cdkn1c_(Cdkn1c)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	RAB19 PODNL1 GUCY2D MOS	3.44e-05	58	141	4	630c9cfbaabacd99f4519f1f960fb59ca3b6fe9c
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Cdkn1c_(Cdkn1c)--\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	RAB19 PODNL1 GUCY2D MOS	3.44e-05	58	141	4	44ac4a3e212fb202a066a913d9116f50fe255f6e
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SLIT2 GYG1 RORA LUM PLEKHH2 SEMA3E	3.49e-05	193	141	6	9f69edc97b868d23998abc98928a2e89a885ef8a
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPN12 LRAT GLT8D2 MYO10 NRXN2 PLXNC1	3.49e-05	193	141	6	2483bb7f398e4fa0ef09c8bd584ed25703853f03
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	ZNF536 RYR2 SLIT2 RORA LUM PLEKHH2	3.49e-05	193	141	6	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	MYO10 RYR2 SLIT2 RORA LUM PLEKHH2	3.49e-05	193	141	6	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	RYR2 SLIT2 RORA DCLK2 LUM PLEKHH2	3.60e-05	194	141	6	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	AXL SLIT2 RORA ZFHX3 LUM PLEKHH2	3.60e-05	194	141	6	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	GLT8D2 SLIT2 GYG1 RORA LUM PLEKHH2	3.60e-05	194	141	6	8c37bedb23285735ff3828db3889897fada8c95d
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MYO10 LRRTM3 SLIT2 RORA LUM PLEKHH2	3.70e-05	195	141	6	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 IQGAP1 RAD51AP2 RIF1 PRSS53 HERC1	3.70e-05	195	141	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYO10 SLIT2 LRRN3 RASGEF1B LUM PLEKHH2	3.81e-05	196	141	6	6730743cf088c419ccc2d28765769fc09d3ba6a7
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYO10 SLIT2 LRRN3 RASGEF1B LUM PLEKHH2	3.81e-05	196	141	6	21dab89f3699037138a9c7a0e4dc98739a9fad9c
ToppCell	Bronchial-NucSeq-Stromal-Schwann\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LRAT ZNF536 PCDHB4 LGR5 LGI4 SLIT2	3.81e-05	196	141	6	a90c76d9c57a4491b94a321ba541b792ec5d8e83
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GLT8D2 FAM114A1 ZNF536 AGT RORA DOCK6	3.81e-05	196	141	6	9d7b631f24a19a7dc7a28f28525d4019fc8fcf8a
ToppCell	Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PODNL1 KIAA0930 PCDHB4 PCDHB2 AGT LUM	3.92e-05	197	141	6	4edf043e8f586fd375f56485841fe992a18bf853
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GLT8D2 FAM114A1 ZNF536 AGT RORA DOCK6	3.92e-05	197	141	6	7d97c2d51a543c02d679e9257b22d0581e73a11d
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AXL PCDHB8 LRRTM3 LGI4 RYR2 AGT	3.92e-05	197	141	6	cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c
ToppCell	COPD-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	RYR2 SLIT2 LRRN3 RORA LUM PLEKHH2	3.92e-05	197	141	6	d51f484b4e01ac64233950d0b97fa88825ea1dbb
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GLT8D2 FAM114A1 ZNF536 AGT RORA DOCK6	3.92e-05	197	141	6	671d6b5effbac2dd71d18f48d23c523738db1828
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PCSK1 TMPRSS9 LRRTM3 RYR2 AGT SEMA3E	3.92e-05	197	141	6	3a0e97bfebe82f9687d518baaad7f20d0ffea8a1
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYO10 SLIT2 GYG1 RORA LUM PLEKHH2	3.92e-05	197	141	6	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PODNL1 GLT8D2 SLIT2 AGT LUM PLEKHH2	4.03e-05	198	141	6	300d7cc56207d77168390fa1ffcbcf76767b1b80
ToppCell	3'-Adult-LargeIntestine-Neuronal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRAT ZNF536 AXL PCDHB2 LGI4 AGT	4.03e-05	198	141	6	2488ea95003f218afb25ecc873805b825e6cc409
ToppCell	distal-mesenchymal-Myofibroblast-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PODNL1 GLT8D2 ZNF536 LGR5 LUM PLEKHH2	4.03e-05	198	141	6	beef5075ba6dcd4d0a447bc4e57efcaf2e93c546
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	B4GAT1 ASIC1 NRXN2 CSPG4 AKR1C3 SEMA3E	4.03e-05	198	141	6	02d0d8a212e09c0962ab1dae6a885d26d357f66a
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	LRRTM3 SLIT2 AGT RAI14 LUM PLEKHH2	4.03e-05	198	141	6	a8c21f4db6730d0aa05b61fbe72bf9f7571a9015
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	LRRTM3 SLIT2 AGT RAI14 LUM PLEKHH2	4.03e-05	198	141	6	8b68fc887e5ad0a59ea4d93dfd1edda67030f142
ToppCell	3'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRAT ZNF536 AXL PCDHB2 LGI4 AGT	4.03e-05	198	141	6	991db02a76f7506848827601e927cf997cb520d3
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	LRRTM3 SLIT2 AGT RAI14 LUM PLEKHH2	4.03e-05	198	141	6	4739b2e4ab141c66772e61686b45614a1839483e
ToppCell	3'-Adult-LargeIntestine-Neuronal-Glial_mature\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRAT ZNF536 AXL PCDHB2 LGI4 AGT	4.03e-05	198	141	6	98ab27335d126fa7817a46953948e524d91248f8
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DOCK3 ASIC1 HIP1R LRRTM3 CSPG4 PLEKHH2	4.14e-05	199	141	6	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	FCHSD2 NF1 RASGEF1B RORA TNKS HERC1	4.14e-05	199	141	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	MYO10 CBFA2T3 LGI4 RYR2 CSPG4 DOCK6	4.26e-05	200	141	6	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	PODNL1 GLT8D2 FAM114A1 KIAA0930 LUM SNRNP200	4.26e-05	200	141	6	eabb7d4aa92ace7d970bcd3fae2c7cb5400a43b4
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYO10 CBFA2T3 LGI4 RYR2 CSPG4 DOCK6	4.26e-05	200	141	6	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	control-cDC\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KIAA0930 AXL CBFA2T3 RYR1 ZFHX3 EIF2AK4	4.26e-05	200	141	6	4a6d17a4225be38537d3dd8a39512051f597f4e0
Drug	IAA-94	PCSK1 RYR1 RYR2 AGT PKD1 TRPV6	2.04e-06	61	140	6	CID000003667
Drug	Loracarbef [121961-22-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A	LRAT RYR1 UBA7 NF1 ATP8A1 FGF21 TLR2 PPP1R37 TRPV6	3.89e-06	198	140	9	3532_UP
Drug	gadolinium	ASIC1 RYR1 RYR2 GH1 GH2 NF1 PKD1 TRPV6 TRPV5	4.06e-06	199	140	9	CID000023982
Drug	Bay K 8644	RYR1 RYR2 NF1 MAP4K5 AGT PKD1 TRPV6 TRPV5	4.22e-06	150	140	8	CID000002303
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A	KIAA0930 B4GAT1 ASIC1 ZCCHC14 UBA7 NF1 PNPLA6 NFIC PI4KB	4.23e-06	200	140	9	1165_DN
Drug	CAS 298-57-7	RYR1 RYR2 RIF1 PKD1 TRPV6 PLS1	5.89e-06	73	140	6	CID000002761
Drug	AC1NBU2S	RYR1 RYR2 GUCY1B2 AGT GUCY2D PKD1 TRPV6	8.07e-06	117	140	7	CID004473765
Drug	Cinildipine	RYR1 RYR2 AGT PKD1 TRPV6	2.43e-05	56	140	5	CID000002752
Drug	Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; PC3; HT_HG-U133A	PODNL1 CLTCL1 RYR2 KLHL22 PLXNC1 AGT TLR2 MTMR3	2.46e-05	191	140	8	4580_UP
Drug	Lynestrenol [52-76-6]; Up 200; 14uM; HL60; HG-U133A	PODNL1 CLTCL1 ASIC1 ZNF268 NF1 PLXNC1 MTMR3 PLS1	2.85e-05	195	140	8	2037_UP
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; HL60; HT_HG-U133A	DLG5 SLIT2 RIF1 ATP8A1 ANGEL2 CSPG4 DZIP3 DOCK6	3.18e-05	198	140	8	2176_UP
Drug	Paroxetine maleate [64006-44-6]; Up 200; 1uM; MCF7; HT_HG-U133A	LRAT MARCHF6 HIP1R MTMR3 TENM1 PPP1R37 RORA SNRNP200	3.18e-05	198	140	8	4378_UP
Drug	nitrendipine	RYR1 RYR2 MAP4K5 AGT PKD1 TRPV6	3.21e-05	98	140	6	CID000004507
Drug	Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A	DLG5 KLHL22 ZCCHC14 SLIT2 MTMR3 DZIP3 PPP1R37 DNAJC3	3.30e-05	199	140	8	4691_DN
Drug	Amethopterin (R,S) [59-05-2]; Up 200; 8.8uM; PC3; HT_HG-U133A	PODNL1 ASIC1 ZNF268 HIP1R ZCCHC14 NRXN2 CSPG4 BAIAP3	3.30e-05	199	140	8	6654_UP
Drug	nilvadipine	RYR1 RYR2 AGT PKD1 TRPV6	3.41e-05	60	140	5	CID000004494
Drug	Vitexin [3681-93-4]; Up 200; 9.2uM; PC3; HT_HG-U133A	ZNF268 RYR2 NF1 NRXN2 PLXNC1 AGT TENM1 DOCK6	3.42e-05	200	140	8	4588_UP
Drug	isradipine	ASIC1 RYR1 RYR2 AGT PKD1 TRPV6	3.60e-05	100	140	6	CID000003784
Drug	lercanidipine	RYR1 RYR2 AGT PKD1 TRPV6	4.32e-05	63	140	5	CID000065866
Drug	CNS 1145	RYR1 RYR2 PKD1 TRPV6	4.88e-05	33	140	4	CID000190902
Drug	IHC-64	RYR1 RYR2 PKD1 TRPV6	4.88e-05	33	140	4	CID000162753
Drug	hydride	DOCK3 B4GAT1 RPS6KA5 ASIC1 NDUFA10 RYR1 RIF1 UBA7 ATP6V0D1 GUCY1B2 MAP4K5 GYG1 GUCY2D AKR1C3 TNKS CLCF1	5.70e-05	835	140	16	CID000000783
Drug	AC1L2AC7	RYR1 RYR2 AGT PKD1 TRPV6	6.70e-05	69	140	5	CID000068733
Disease	alkaline phosphatase measurement	NBPF3 DLG5 MACC1 RPS6KA5 FARP2 PHKB NF1 MAP4K5 FGF21 PKD1 PPP1R37 RAI14 TNKS PLEKHH2 ALPK2 DNMT1	1.71e-05	1015	135	16	EFO_0004533
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR2	6.21e-05	3	135	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR2	6.21e-05	3	135	2	DOID:8545 (implicated_via_orthology)
Disease	lumican measurement	GLT8D2 LUM	1.24e-04	4	135	2	EFO_0021889
Disease	ANGPTL8 measurement	MAP4K5 DOCK6	1.24e-04	4	135	2	EFO_0020861
Disease	hemoglobin A1 measurement	PCSK1 LRRC66 DLG5 GH2 NFIC MAP4K5 MTMR3 TRPV6 SNRNP200 DNASE1	1.46e-04	520	135	10	EFO_0007629
Disease	creatinine measurement	CAPN12 RAB19 USP11 RYR1 STAT3 NRXN2 PLXNC1 MAP4K5 CSPG4 MTMR3 ZFHX3 PNPLA7 WDR1 PLEKHH2	1.95e-04	995	135	14	EFO_0004518
Disease	isolated growth hormone deficiency type II (implicated_via_orthology)	GH1 GH2	2.06e-04	5	135	2	DOID:0060872 (implicated_via_orthology)
Disease	Schwannomatosis, Plexiform	AXL NF1	2.06e-04	5	135	2	C0751374
Disease	Inflammation	ASIC1 STAT3 AGT TLR2 WDR1	3.03e-04	127	135	5	C0021368
Disease	Neurilemmoma	AXL NF1	3.08e-04	6	135	2	C0027809
Disease	phosphate measurement	NBPF3 LEMD2	4.30e-04	7	135	2	EFO_0010968
Disease	isolated growth hormone deficiency (implicated_via_orthology)	GH1 GH2	4.30e-04	7	135	2	DOID:0060870 (implicated_via_orthology)
Disease	cerebellar ataxia (implicated_via_orthology)	PNPLA6 PNPLA7	5.71e-04	8	135	2	DOID:0050753 (implicated_via_orthology)
Disease	blindness (implicated_via_orthology)	PNPLA6 PNPLA7	5.71e-04	8	135	2	DOID:1432 (implicated_via_orthology)
Disease	response to anti-thyroid drug, Drug-induced agranulocytosis	MOS MOCOS	5.71e-04	8	135	2	EFO_0007838, HP_0012235
Disease	body shape measurement	TGFBRAP1 DNASE1	5.71e-04	8	135	2	EFO_0801227
Disease	Autism Spectrum Disorders	LRRTM3 RYR2 LRRN3 NRXN2	6.37e-04	85	135	4	C1510586
Disease	alanine measurement	CLTCL1 SF3B3 MAP4K5 RORA	6.66e-04	86	135	4	EFO_0009765
Disease	testosterone measurement	PCSK1 DOCK3 EFL1 ZNF536 AMER1 FXR2 IQGAP1 FARP2 ATP6V0D1 NF1 MAP4K5 TGFBRAP1 AKR1C3 RORA ZFHX3	7.56e-04	1275	135	15	EFO_0004908
Disease	body surface area	PCSK1 LRRC66 AXIN2 NFIC MAP4K5 MTMR3 RORA ZFHX3 LUM DNMT1	7.75e-04	643	135	10	EFO_0022196
Disease	transient cerebral ischemia (biomarker_via_orthology)	AXIN2 SLIT2 NF1 AGT SEMA3E	7.96e-04	157	135	5	DOID:224 (biomarker_via_orthology)
Disease	retinitis pigmentosa (is_implicated_in)	LRAT GUCY2D SNRNP200	8.79e-04	41	135	3	DOID:10584 (is_implicated_in)
Disease	basophil percentage of leukocytes	KIAA0930 DPP8 RYR1 IQGAP1 PRKDC CLCF1	9.10e-04	243	135	6	EFO_0007992
Disease	protein intake measurement	MAP4K5 FGF21	9.13e-04	10	135	2	EFO_0010810
Disease	apolipoprotein B measurement	STAT3 IQGAP1 FARP2 NF1 MAP4K5 FGF21 PPP1R37 ZFHX3 PLEKHH2 DOCK6	9.77e-04	663	135	10	EFO_0004615
Disease	liver fat measurement	MAP4K5 TGFBRAP1 DNASE1	1.01e-03	43	135	3	EFO_0010821
Disease	hereditary spastic paraplegia (implicated_via_orthology)	CAPN12 PNPLA6 PNPLA7	1.01e-03	43	135	3	DOID:2476 (implicated_via_orthology)
Disease	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA	AXL SEMA3E	1.11e-03	11	135	2	146110
Disease	Hypogonadotropic hypogonadism 7 with or without anosmia	AXL SEMA3E	1.11e-03	11	135	2	cv:C0342384
Disease	autoimmune hepatitis (is_marker_for)	ZFHX3 DNASE1	1.11e-03	11	135	2	DOID:2048 (is_marker_for)
Disease	Diabetic Cardiomyopathies	RYR2 AGT	1.11e-03	11	135	2	C0853897
Disease	fibroblast growth factor 21 measurement	MAP4K5 FGF21	1.11e-03	11	135	2	EFO_0010783
Disease	severe acute respiratory syndrome (is_marker_for)	GH1 TLR2 CLCF1	1.31e-03	47	135	3	DOID:2945 (is_marker_for)
Disease	Malignant neoplasm of breast	ANKRD29 B4GAT1 PCDHB15 MAMDC4 STAT3 ZCCHC14 PHKB RIF1 NF1 MTMR3 TENM1 ZNF281 DNMT1	1.33e-03	1074	135	13	C0006142
Disease	IGFBP-1 measurement	MYO10 TGFBRAP1	1.57e-03	13	135	2	EFO_0005118
Disease	skin melanoma (is_marker_for)	STAT3 AGT	1.57e-03	13	135	2	DOID:8923 (is_marker_for)
Disease	congenital hypothyroidism (biomarker_via_orthology)	GH1 GH2	1.82e-03	14	135	2	DOID:0050328 (biomarker_via_orthology)
Disease	triacylglycerol 52:1 measurement	MAP4K5 RORA	1.82e-03	14	135	2	EFO_0010413
Disease	polycystic kidney disease (implicated_via_orthology)	AGT PKD1	1.82e-03	14	135	2	DOID:0080322 (implicated_via_orthology)
Disease	body weight	PCSK1 LRRC66 RPS6KA5 AXIN2 GH1 GH2 SLIT2 NFIC MAP4K5 GYG1 PKD1 MTMR3 RORA ZFHX3	1.96e-03	1261	135	14	EFO_0004338
Disease	Metastatic melanoma	GUCY2D PRKDC ALPK2	1.96e-03	54	135	3	C0278883
Disease	hepatoblastoma (is_marker_for)	AXIN2 ZFHX3	2.10e-03	15	135	2	DOID:687 (is_marker_for)
Disease	YKL40 measurement	MAP4K5 RORA	2.10e-03	15	135	2	EFO_0004869
Disease	cathepsin D measurement	MAP4K5 FGF21	2.10e-03	15	135	2	EFO_0010611
Disease	eosinophil percentage of leukocytes	DOCK3 NAA60 FARP2 FAM193A PLXNC1 MAP4K5 RORA PRKDC CLCF1 ALPK2	2.33e-03	746	135	10	EFO_0007991
Disease	Leber congenital amaurosis	LRAT GUCY2D	2.39e-03	16	135	2	cv:C0339527
Disease	Obesity	PCSK1 GH1 FGF21 AKR1C3 ZFHX3	2.58e-03	205	135	5	C0028754
Disease	puberty onset measurement	DOCK3 ZNF536 MAP4K5 RORA	2.65e-03	125	135	4	EFO_0005677
Disease	protein-glutamine gamma-glutamyltransferase e measurement	DLG5 MAP4K5 RORA	2.65e-03	60	135	3	EFO_0020690
Disease	Glycogen storage disease	PHKB GYG1	2.70e-03	17	135	2	cv:C0017919
Disease	glomerulonephritis (implicated_via_orthology)	AXL C6	2.70e-03	17	135	2	DOID:2921 (implicated_via_orthology)
Disease	dermatomyositis (is_marker_for)	SLIT2 TLR2	2.70e-03	17	135	2	DOID:10223 (is_marker_for)
Disease	Idiopathic hypogonadotropic hypogonadism	AXL SEMA3E	3.03e-03	18	135	2	C0342384
Disease	Cardiomyopathies	STAT3 RYR2 AGT TLR2	3.05e-03	130	135	4	C0878544
Disease	neuroticism measurement	DOCK3 ZNF536 ZNF507 CBFA2T3 ZCCHC14 PLXNC1 RORA TNKS WDR1 HERC1 SEMA3E	3.13e-03	909	135	11	EFO_0007660
Disease	reticulocyte count	NFIC MAP4K5 PKD1 MTMR3 DZIP3 RORA RAI14 EIF2AK4 HERC1 BAIAP3 PLS1 DNMT1	3.13e-03	1045	135	12	EFO_0007986
Disease	serum gamma-glutamyl transferase measurement	DLG5 AXL RYR2 FARP2 NF1 MAP4K5 FGF21 PKD1 RORA ALPK2 DNMT1	3.26e-03	914	135	11	EFO_0004532
Disease	bitter alcoholic beverage consumption measurement	NF1 NRXN2 MAP4K5 ZFHX3	3.31e-03	133	135	4	EFO_0010092
Disease	facial asymmetry measurement	MYO10 RORA	3.38e-03	19	135	2	EFO_0009751
Disease	dilated cardiomyopathy	FHOD3 PKD1	3.74e-03	20	135	2	EFO_0000407
Disease	Abnormality of refraction	DOCK3 AXIN2 MAP4K5 MTMR3 RORA ZFHX3 C6 MOS MOCOS	3.89e-03	673	135	9	HP_0000539
Disease	Cardiomyopathies, Primary	STAT3 AGT TLR2	3.94e-03	69	135	3	C0033141
Disease	Myocardial Diseases, Secondary	STAT3 AGT TLR2	3.94e-03	69	135	3	C0036529
Disease	Left Ventricle Remodeling	AXIN2 AGT	4.12e-03	21	135	2	C0600520
Disease	Ventricular Remodeling	AXIN2 AGT	4.12e-03	21	135	2	C0600519
Disease	sex interaction measurement, COVID-19	MACC1 ZNF536	4.12e-03	21	135	2	EFO_0008343, MONDO_0100096
Disease	saturated fatty acids to total fatty acids percentage	MAP4K5 FGF21	4.12e-03	21	135	2	EFO_0022305
Disease	serum metabolite measurement	NBPF3 STAT3 SLIT2 PHKB MAP4K5 AKR1C3 RORA ZFHX3 WDR1 DOCK6 DNMT1	4.19e-03	945	135	11	EFO_0005653
Disease	dilated cardiomyopathy (biomarker_via_orthology)	AXIN2 AGT	4.52e-03	22	135	2	DOID:12930 (biomarker_via_orthology)
Disease	osteoporosis (biomarker_via_orthology)	GH1 GH2	4.52e-03	22	135	2	DOID:11476 (biomarker_via_orthology)
Disease	Leber Congenital Amaurosis	LRAT GUCY2D	4.52e-03	22	135	2	C0339527
Disease	carotid artery disease (is_implicated_in)	AGT LUM	4.52e-03	22	135	2	DOID:3407 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
AHSYVALDDLLLQDG	MAMDC4	951	Q6UXC1
DLLDGAVLYSHNGSL	CSPG4	1191	Q6UVK1
LNKDLSLENGAHAYN	DNMT1	86	P26358
TAQLLSGLDYLHSNS	EIF2AK4	406	Q9P2K8
HQTCTLDYSYLLGLL	BAIAP3	466	O94812
SLLSGLHGQEEQDQY	B4GAT1	31	O43505
IANGLLFLNSSHIYE	ALPK2	211	Q86TB3
IDGLDRNLHYFNSDS	AKR1C3	296	P42330
SLHYATGNEEYLINL	EFL1	76	Q7Z2Z2
ANIHDQLYDGATALF	ANKRD29	136	Q8N6D5
SLHSLLGDQDGAYLF	AXIN2	81	Q9Y2T1
LSNSHLVQGYLESDE	AMER1	906	Q5JTC6
LYDSLLALDGHIQSA	CLDN19	66	Q8N6F1
SYNILSQDLLEDNSH	ANGEL2	171	Q5VTE6
GADILSNTFYSNELH	C7orf31	16	Q8N865
GLAHIQQLYDLLSND	DHX29	876	Q7Z478
HNLENLESLYLGSNH	CD180	146	Q99467
LYYQLGDHELSLSEV	DNAJC3	231	Q13217
QAHQFISLLLEEYGA	FAM193A	26	P78312
LYRSESLQQNLLHGY	ATP8A1	1121	Q9Y2Q0
DSKSLEAYLNQHLSG	ACAD11	21	Q709F0
SLYLGALDHTADRLQ	AGT	136	P01019
FLGDNAHLSIINEYL	IQGAP1	1241	P46940
LALLLFVHYSNGDES	P4HTM	76	Q9NXG6
NDSALYINHQFETGL	RAD51AP2	921	Q09MP3
LNLVDSLGYNALHYS	RAI14	211	Q9P0K7
ARNSLHLYGESALNG	RAB19	181	A4D1S5
NADNGHLFALRSLDY	PCDHB5	506	Q9Y5E4
DNGHLFALQSLDYEA	PCDHB2	511	Q9Y5E7
VTFLALHNYLGLTNE	PNPLA6	326	Q8IY17
ALGFNSISLDYQHLR	KIAA0100	441	Q14667
LLGATLENDSHDYIF	LINS1	16	Q8NG48
NAQALLEYHLSYLQE	FXR2	356	P51116
NDLYTLFDAIIGSHD	GUCY2D	906	Q02846
ELLHELYNFLAIQAG	LEMD2	271	Q8NC56
LDYIQHLGSALASLS	NAA60	191	Q9H7X0
SFAGLASLQELYLNH	LRRN2	136	O75325
DHYLDALLSSQLALA	HERC1	76	Q15751
LNRADGNFLLYAHLT	KIAA0930	366	Q6ICG6
VYNLANALRYLHGLS	DCLK2	496	Q8N568
NPYINHLYSDLADAL	PLS1	411	Q14651
DQLDYSLEHSLSRLY	PLXNC1	66	O60486
HLNDTLSYFLLNGTD	FAT2	1996	Q9NYQ8
SDDFLLGNHGYDNAL	ENPP5	331	Q9UJA9
LLLEDGYNVYQSEAH	FGF21	126	Q9NSA1
SIAHQAGLEYGDQLL	DLG5	1381	Q8TDM6
AALRLQYLQGDYTLH	MYO10	1831	Q9HD67
GYLLDLHSYLLGDQE	MARCHF6	561	O60337
FAYGANILVNHLDES	LRAT	116	O95237
QELYDTTLALGHAAA	GLT8D2	166	Q9H1C3
YLDHAGATLFSQSQL	MOCOS	51	Q96EN8
LDYINGGELFTHLSQ	RPS6KA5	131	O75582
LILSLDYNLHGAFQQ	PLA2G4B	636	P0C869
GHLFALQSLDYEALQ	PCDHB15	511	Q9Y5E8
YLAQHEQLLLDASAS	CBFA2T3	261	O75081
LYYHDNNLLSGSLEA	RASGEF1B	31	Q0VAM2
GLYSHLLDQLYELNV	NEURL2	166	Q9BR09
ENISLDYHQLSVYLG	DZIP3	556	Q86Y13
LHNYLGLTTELFNAE	PNPLA7	281	Q6ZV29
LAVHEDGLSLLEYNS	PLEKHH2	1371	Q8IVE3
AYLHALEVLNLSNNA	LRRC66	106	Q68CR7
TGLHSLVALYLDNSN	LRRC70	81	Q7Z2Q7
LQYSDALEHLLTTGQ	NDUFA10	141	O95299
LDLRNNHVLDSGLAY	PPP1R37	281	O75864
NADNGHLFALRSLDY	PCDHB4	506	Q9Y5E5
DSASGLGDYLQLHID	NRXN2	136	P58401
YLQHNQLTDSGLDAT	PODNL1	246	Q6PEZ8
TLADYLHLLQAAAQA	PPCS	151	Q9HAB8
YSLQEQHLGLALDLD	NBPF3	446	Q9H094
NSYELRLALNAAGFH	CAPN12	641	Q6ZSI9
LEEGHAQYLTSLADA	HIP1R	671	O75146
YNQLLHLASEQGSFD	GYG1	146	P46976
GALLYHYSLEQVQAD	KLHL22	216	Q53GT1
DENSTFNNHALYLGL	DOCK3	551	Q8IZD9
LYSLGSAQSALFLQH	DOCK6	1421	Q96HP0
ALNHLPLEYNSALYS	C6	341	P13671
YGLSDQLAQAISDHY	DNASE1	261	P24855
YELHLLHYLQENLGS	DPP8	876	Q6V1X1
LDDCTLQLSHNGAYL	FHOD3	56	Q2V2M9
LQLSHNGAYLDLEAT	FHOD3	61	Q2V2M9
LQYLRLSHNELADSG	LUM	231	P51884
LGYSHLSLEDFDQIQ	MACC1	671	Q6ZN28
ANSHYFALIDQLIEG	MAN2A2	256	P49641
HARNDYLLTLAAANA	FCHSD2	206	O94868
YLLTLAAANAHQDRY	FCHSD2	211	O94868
ALLTSHLLQSEIGDY	FARP2	161	O94887
FDHLSYLLENSGIGL	RYR1	2251	P21817
DHLSYLLENSSVGLA	RYR2	2216	Q92736
EYGHLQINAVSLYLL	PHKB	166	Q93100
DGLHSLETLDLNYNN	LGR5	231	O75473
DGIYTLNLNELHEAT	MAP4K5	531	Q9Y4K4
LESQYLTSSLHFNGD	MTMR3	1056	Q13615
HLQLNYTLLDGHYLS	PKD1	2921	P98161
YQGLSHLEALEILSN	FAM114A1	296	Q8IWE2
NGHLFALRSLDYEAL	PCDHB8	511	Q9UN66
YSLDVVNGLLFLHSQ	MOS	181	P00540
ISNTYGLDYVHNLNL	MT-ND4L	81	P03901
NLLAHFINAYLVDDS	MTCH1	271	Q9NZJ7
YLDIARYLLSHGANI	PPP1R12C	146	Q9BZL4
RNLDLSYNQLHSLGS	LRRTM3	136	Q86VH5
LNSNALSALYHGTIE	LRRN3	341	Q9H3W5
IEDDAFAGLSHLQYL	LGI4	91	Q8N135
FAGLSHLQYLFIEDN	LGI4	96	Q8N135
LQLDSEDLHNYSGSQ	RIF1	2426	Q5UIP0
DLVLGLSHLNNSYNF	GPR108	191	Q9NPR9
NLDALHSYLALSYQE	GUCY1B2	21	O75343
RYSYDLNGNINLLSH	TENM1	2171	Q9UKZ4
HLLSVSLSGYINYLD	WDR1	291	O75083
NFSLGELQGHLAYDL	NFIC	246	P08651
SQLSLLDYFLQEHGS	PI4KB	626	Q9UBF8
NEAQLGFYLGSLSHL	SLX4	6	Q8IY92
NDLYHAGELLALLNN	ASIC1	106	P78348
GLLQQALEHYTDLYD	CLTCL1	621	P53675
EHQLRSLAGTYLNYL	CLCF1	51	Q9UBD9
LAGAQSYSLHALEDL	C11orf53	156	Q8IXP5
SHNDDALLKNYGLLY	GH2	176	P01242
NHYSQGSDLALLQLA	PRSS53	121	Q2L4Q9
ALGLLYHYNNQDAAA	TGFBRAP1	491	Q8WUH2
LENYSNLVSLGYQHT	ZNF268	111	Q14587
LTNEGSQYLRDYLHL	RPS10P5	71	Q9NQ39
LHDETLTYLNQGQSY	TFCP2	81	Q12800
QDTHLLYVLAAANLY	UBA7	721	P41226
YNISANGLTELHDDL	RORA	186	P35398
DTRYLEQLHQLYSDS	STAT3	11	P40763
LHLAAGYNNLEVAEY	TNKS	841	O95271
GDLHSFLLYSRLGDQ	AXL	626	P30530
ELLDQALCASLYGHS	TMPRSS9	351	Q7Z410
YNLLLSYDRHGDHLQ	TRPV6	256	Q9H1D0
GLYLSALDATHQQLT	ZNF281	746	Q9Y2X9
YSAGTALLEQNLHTL	NF1	2331	P21359
SHNDDALLKNYGLLY	GH1	176	P01241
AFQDLHNLNLLSLYD	SLIT2	391	O94813
QTLTFYELDLGLNHV	SF3B3	206	Q15393
HYSQELSLLYLLQDD	PRKDC	3081	P78527
DFLSHGLNQTLEYNL	ZNF536	606	O15090
TSHGELQYYLSLLNQ	SNRNP200	871	O75643
NHVDLDSGLRYLASL	ZCCHC14	171	Q8WYQ9
TRANLGHYGDINLLD	ZNF507	511	Q8TCN5
EEHLAYGIENNSTLL	SEMA3E	586	O15041
YDLASGNLLETIDAH	WDR3	481	Q9UNX4
GLEGDISLYNTLAQH	TUT4	1066	Q5TAX3
SLEHLDLSYNYLSNL	TLR2	101	O60603
QRLGAALHALQDFYS	VWA7	161	Q9Y334
YQQHDSQELLSFLLD	USP11	396	P51784
YNLLLSYDGHGDHLQ	TRPV5	216	Q9NQA5
SHLELSEADIQQLYG	ZFHX3	1451	Q15911
KLHLQSTDYGNFLAN	ATP6V0D1	46	P61421
DLLGQIGSLENHYLF	PCSK1	56	P29120